Boryung Corporation

Equities

A003850

KR7003850005

Pharmaceuticals

End-of-day quote Korea S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
10,930 KRW -0.18% Intraday chart for Boryung Corporation -1.09% -8.07%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Tranche Update on Boryung Corporation's Equity Buyback Plan announced on November 9, 2020. CI
Tranche Update on Boryung Corporation's Equity Buyback Plan announced on November 9, 2020. CI
Tranche Update on Boryung Corporation's Equity Buyback Plan announced on November 9, 2020. CI
Tranche Update on Boryung Corporation's Equity Buyback Plan announced on November 9, 2020. CI
Tranche Update on Boryung Corporation's Equity Buyback Plan announced on November 9, 2020. CI
Tranche Update on Boryung Corporation's Equity Buyback Plan announced on January 8, 2014. CI
Tranche Update on Boryung Corporation's Equity Buyback Plan announced on July 3, 2012. CI
Tranche Update on Boryung Corporation's Equity Buyback Plan announced on March 30, 2011. CI
Boryung Corporation's Equity Buyback announced on January 8, 2014, has expired with 132,205 shares, representing 0.24% for KRW 996.97 million. CI
Boryung Corporation's Equity Buyback Plan announced on March 30, 2011, has expired with 205,808 shares, representing 0.37% for KRW 1.19 million. CI
Boryung Corporation's Equity Buyback Plan announced on July 3, 2012, has expired with 332,770 shares, representing 0.61% for KRW 1,081.11 million. CI
Boryung Corporation's Equity Buyback Plan announced on February 3, 2006, has expired. CI
Boryung Corporation's Equity Buyback announced on November 9, 2020 has expired with 619,992 shares, representing 1% for KRW 10,013.49 million. CI
Boryung Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Boryung and Axiom Space Join Forces for Space Ventures MT
Intuitive Machines Partners With South Korea's Boryung; Announces COO Appointment, CFO Departure MT
Boryung Corporation(KOSE:A003850) dropped from KOSPI 200 Index CI
Boryung Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Axiom Space raises $350 mln in round led by Saudi, Korean investors RE
Axiom Space, Inc. announced that it has received $350 million in funding from Boryung Corporation, AlJazira Capital Company CI
Axiom Space, Inc. announced that it has received $350 million in funding from Boryung Corporation, AlJazira Capital Company CI
Boryung Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
South Korea's FTC Imposes 40.9 Billion Won in Fines on Drug Firms for Bid-Rigging MT
Boryung Corporation Partners with Axiom Space and Aurelia Institute to Launch the "2023 Humans in Space" Program CI
Boryung Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Chart Boryung Corporation
More charts
Boryung Corp, formerly Boryung Pharm Co Ltd, is a Korea-based company principally engaged in the manufacture and sale of pharmaceutical products. The Company mainly manufactures and distributes pharmaceutical products including antihypertensive drugs, gastrointestinal disorder drugs, antibiotics, gastric ulcer drugs, oral antibiotics, anticancer drugs and antihyperlipidemic drugs, among others. The Company distributes its products in domestic and overseas markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
10,930 KRW
Average target price
15,333 KRW
Spread / Average Target
+40.29%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A003850 Stock
  4. News Boryung Corporation
  5. Boryung's Net Income Rises in Q1; Shares Down 3%